|
[1]
|
Sung, H., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Balkwill, F. and Mantovani, A. (2001) Inflammation and Cancer: Back to Virchow? The Lancet, 357, 539-545. [Google Scholar] [CrossRef]
|
|
[3]
|
Maeda, H. and Akaike, T. (1998) Nitric Oxide and Oxygen Radicals in Infection, Inflammation, and Cancer. Biochemistry, 63, 854-865.
|
|
[4]
|
Coussens, L.M. and Werb, Z. (2002) Inflammation and Cancer. Nature, 420, 860-867. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Dmitrieva, O.S., Shilovskiy, I.P., Khaitov, M.R., et al. (2016) Interleu-kins 1 and 6 as Main Mediators of Inflammation and Cancer. Biochemistry (Moscow), 81, 80-90. [Google Scholar] [CrossRef]
|
|
[6]
|
Zhang, L., et al. (2012) Role of the Microenvironment in Mantle Cell Lymphoma: IL-6 Is an Important Survival Factor for the Tumor Cells. Blood, 120, 3783-3792. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Satomi, A., Murakami, S., Ishida, K., et al. (1995) Significance of Increased Neutrophils in Patients with Advanced Colorectal Cancer. Acta Oncologica, 34, 69-73. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Kitayama, J., et al. (2010) Circulating Lymphocyte Number Has a Positive Association with Tumor Response in Neoadjuvant Chemoradiotherapy for Advanced Rectal Cancer. Radiation Oncology, 5, 47. [Google Scholar] [CrossRef]
|
|
[9]
|
Satomi, A., et al. (1995) Significance of Increased Neutrophils in Pa-tients with Advanced Colorectal Cancer. Acta Oncologica, 34, 69-73. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Abu-Shawer, O., et al. (2020) The Clinical Value of Peripheral Immune Cell Counts in Pancreatic Cancer. PLoS ONE, 15, e0232043. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Wang, D., et al. (2019) Preoperative Inflammatory Markers of NLR and PLR as Indicators of Poor Prognosis in Resectable HCC. PeerJ, 7, e7132. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Duan, J., Pan, L. and Yang, M. (2018) Preoperative Elevated Neutro-phil-to-Lymphocyte Ratio (NLR) and Derived NLR Are Associated with Poor Prognosis in Patients with Breast Cancer: A Meta-Analysis. Medicine (Baltimore), 97, e13340. [Google Scholar] [CrossRef]
|
|
[13]
|
Diem, S., et al. (2017) Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) as Prognostic Markers in Patients with Non-Small Cell Lung Cancer (NSCLC) Treated with Nivolumab. Lung Cancer, 111, 176-181. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Cho, I.R., et al. (2014) Pre-Treatment Neutrophil to Lympho-cyte Ratio as a Prognostic Marker Topredict Chemotherapeutic Response and Survival Outcomes in Metastatic Advanced Gastric Cancer. Gastric Cancer: Official Journal of the International Gastric Cancer Association and the Japanese Gas-tric Cancer Association, 17, 703-710. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Jeon, T.J. and Park, J.Y. (2017) Clinical Significance of the Neu-trophil-Lymphocyte Ratio as an Early Predictive Marker for Adverse Outcomes in Patients with Acute Pancreatitis. World Journal of Gastroenterology, 23, 3883-3889. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Xu, N., Tang, X.-F., Yao, Y., et al. (2018) Predictive Value of Neu-trophil to Lymphocyte Ratio in Long-Term Outcomes of Left Main and/Or Three-Vessel Disease in Patients with Acute Myocardial Infarction. Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiac An-giography and Interventions, 91, 551-557. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Wilcox, R.A., Wada, D.A., Ziesmer, S.C., et al. (2009) Monocytes Promo-tetumor Cell Survival in T-Cell Lymphoproliferative Disorders and Areimpaired in Their Ability to Differentiate into Mature Dendritic Cells. Blood, 114, 2936-2944. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Whiteside, T.L. (2013) Immune Modulation of T-Cell and NK (Natural Killer) Cell Activities by TEXs (Tumour- Derived Exosomes). Biochemical Society Transactions, 41, 245-251. [Google Scholar] [CrossRef]
|
|
[19]
|
Feng, X.Y., Wen, X.Z., Tan, X.J., et al. (2015) Ectopic Expression of B and Tlymphocyte Attenuator in Gastric Cancer: A Potential Independent Prognostic Factor in Patients with Gastric Cancer. Molecular Medicine Reports, 11, 658-664. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Lin, J.X., et al. (2021) Dynamic Changes in Pre- and Postoperative Levels of Inflammatory Markers and Their Effects on the Prognosis of Patients with Gastric Cancer. Journal of Gastro-intestinal Surgery, 25, 387-396. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Pan, Y.C., et al. (2018) Preoperative Lymphocyte-to-Monocyte Ratio (LMR) Could Independently Predict Overall Survival of Resectable Gastric Cancer Patients. Medicine (Baltimore), 97, e13896. [Google Scholar] [CrossRef]
|
|
[22]
|
Sato, S., et al. (2021) High Postoperative Neutro-phil-Lymphocyte Ratio and Low Preoperative Lymphocyte-Monocyte Ratio Predict Poor Prognosis in Gastric Cancer Patients Receiving Gastrectomy with Positive Lavage Cytology: A Retrospective Cohort Study. Langenbeck’s Archives of Surgery, 406, 2295-2303. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Ma, J.Y. and Liu, Q. (2018) Clinicopathological and Prognostic Significance of Lymphocyte to Monocyte Ratio in Patients with Gastric Cancer: A Meta-Analysis. International Journal of Surgery, 50, 67-71. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Okuno, K., et al. (2021) Preoperative Lymphocyte-to-Monocyte Ra-tio Is the Most Predictive Inflammatory Response Marker of Survival in Gastric Cancer. Langenbeck’s Archives of Sur-gery, 406, 2287-2294. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Franco, A.T., Corken, A. and Ware, J. (2015) Platelets at the In-terface of Thrombosis, Inflammation, and Cancer. Blood, 126, 582-588. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Labelle, M., Begum, S. and Hynes, R.O. (2011) Direct Sig-naling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes Metastasis. Cancer Cell, 20, 576-590. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Velez, J., Enciso, L.J., Suarez, M., et al. (2014) Platelets Promote Mitochondrial Uncoupling and Resistance to Apoptosis in Leukemia Cells: A Novel Paradigm for the Bone Marrow Mi-croenvironment. Cancer Microenvironment, 7, 79-90. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Jain, S., Harris, J. and Ware, J. (2010) Platelets: Linking Hemo-stasis and Cancer. Arteriosclerosis, Thrombosis, and Vascular Biology, 30, 2362-2367. [Google Scholar] [CrossRef]
|
|
[29]
|
Cetinkunar, S., Guzel, H., Emre Gokce, I., et al. (2015) High Levels of Platelet/Lymphocyte Ratio Are Associated with Metastatic Gastric Cancer. Journal of BUON: Official Journal of the Balkan Union of Oncology, 20, 78-83.
|
|
[30]
|
Hirahara, T., et al. (2019) Combined Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Predicts Chemotherapy Response and Prognosis in Patients with Advanced Gastric Can-cer. BMC Cancer, 19, Article No. 672. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Wang, J., Qu, J.L., Li, Z., et al. (2018) Pretreatment Plate-let-to-Lymphocyte Ratio Is Associated with the Response to First-Line Chemotherapy and Survival in Patients with Met-astatic Gastric Cancer. Journal of Clinical Laboratory Analysis, 32, e22185. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Kim, E.Y., et al. (2015) The Platelet-to-Lymphocyte Ratio versus Neutro-phil-to-Lymphocyte Ratio: Which Is Better as a Prognostic Factor in Gastric Cancer? Annals of Surgical Oncology, 22, 4363-4370. [Google Scholar] [CrossRef] [PubMed]
|